EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Contemporary Concise Review 2025: Interstitial Lung Disease

Tonia Magrì iD, Luca Richeldi iD

Respirology · 2026

DOI: 10.1002/resp.70309 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Respirology, 2026. Verfasst von Tonia Magrì und 1 weiteren Autor:innen. Beteiligte Einrichtung: Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidisciplinary discussion remains the cornerstone of ILD diagnosis and management, with recent advances further strengthening the integration of clinical, radiological, pathological, and molecular information. Updated ILD nomenclature and classification better align disease terminology with underlying morphology and pathobiology. Growing emphasis is being placed on the early detection of ILD and on identifying individuals at high risk of progression among those with interstitial lung abnormalities (ILAs). Emerging multi‐omic biomarkers and quantitative imaging techniques are enhancing prognostic stratification and may support future precision medicine approaches. Novel antifibrotic therapies and targeted treatments are expanding therapeutic options beyond IPF, although important unmet needs remain regarding patient selection, treatment response, and disease modification. The integration of clinical, radiological, functional, and molecular information will be fundamental to optimize individualized management and improve long‐term outcomes in patients with ILDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialHumansBiomarkersPrognosisDisease ProgressionPrecision MedicineEarly Diagnosis

Stichwörter der Autor:innen

early diagnosisinterstitial lung diseasesmolecular biomarkersmultidisciplinary diagnosisprecision medicineprogressive pulmonary fibrosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Università Cattolica del Sacro Cuore, Rome, Italy.
  • Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

ORCID-Profile: Tonia Magrì, Luca Richeldi

Zitieren

APA

Magrì, T., & Richeldi, L. (2026). Contemporary Concise Review 2025: Interstitial Lung Disease. Respirology. https://doi.org/10.1002/resp.70309

Vancouver

Magrì T, Richeldi L. Contemporary Concise Review 2025: Interstitial Lung Disease. Respirology. 2026. doi:10.1002/resp.70309

BibTeX
@article{Magr2026,
  author = {Magrì, Tonia and Richeldi, Luca},
  title = {Contemporary Concise Review 2025: Interstitial Lung Disease},
  journal = {Respirology},
  year = {2026},
  doi = {10.1002/resp.70309}
}
Kostenlos starten →